Join to access to all OVN content. Join for Free
The Most Common (or NOT) Interview questions and How to Handle Them
Medical Science Liaison interview tips MSL interview questions building therapeutic area knowledge interview anxiety techniques aligning with company values

The Most Common (or NOT) Interview questions and How to Handle Them


Share This Article


Summary

In this episode, Anita Carvalho joins MSL Talk to share invaluable interview tips for aspiring Medical Science Liaisons. Anita emphasizes the importance of thoroughly researching the company and effectively presenting one's resume. She offers strategies for selling oneself during interviews and tackling common challenges, including specific MSL interview questions. The discussion covers building relationships, mastering therapeutic area knowledge, and managing interview anxiety using techniques like the STAR method. Anita also highlights the significance of aligning with company values and proper post-interview etiquette. The episode concludes with closing remarks and gratitude.

Check out my latest podcast with Anita Carvalho, Talent Acquisition Specialist at FerGene. We discuss the most common (and not so common) MSL interview questions and how to handle them.

We discuss:

 What basic interview questions should you expect
 What are some MSL specific interview questions
 What are some “not so” common and even wacky interview questions
 What are behavioral (situational) interview questions and how to handle them

Click for Source
Medical Science Liaison interview tips, MSL interview questions, building therapeutic area knowledge, interview anxiety techniques, aligning with company values

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Article
Does biomarker use in oncology improve clinical trial failure risk? A large-scale analysis
OVN Avatar Jayson L. Parker, Sebnem S. Kuzulugil, Kirill Pereverzev, Stephen Mac, Gilberto Lopes, Zain Shah, Ashini Weerasinghe, Daniel Rubinger, Adam Falconi, Ayse Bener, Bora Caglayan, Rohan Tangri, Nicholas Mitsakakis

Does biomarker use in oncology improve clinical trial failure risk? A large-scale analysis

Article
Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval
OVN Avatar Avi Cherla, MSc; Huseyin Naci, MHS, PhD; Aaron S. Kesselheim, MD, JD, MPH; Bishal Gyawali, MD, PhD; Elias Mossialos, MD, PhD

Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval

Article
Assessment of Food and Drug Administration- and European Medicines Agency-Approved Systemic Oncology Therapies and Clinically Meaningful Improvements in Quality of Life: A Systematic Review
OVN Avatar Vanessa Arciero, BS, Seanthel Delos Santos, Liza Koshy

Assessment of Food and Drug Administration- and European Medicines Agency-Approved Systemic Oncology Therapies and Clinically Meaningful Improvements in Quality of Life: A Systematic Review

Article
Clinical Educator Oncology Program Improves Adherence by 29%​
Partner Avatar iNIZIO

Clinical Educator Oncology Program Improves Adherence by 29%​

Article
New Book Unites Oncology’s Brightest Minds To Innovate Cancer Cures
OVN Avatar Forbes Books Press Release Official

New Book Unites Oncology’s Brightest Minds To Innovate Cancer Cures

Article
CheckMate-067: Raising the Bar for the Next Decade in Oncology
OVN Avatar Sarah A. Weiss, MD, and Harriet Kluger, MD

CheckMate-067: Raising the Bar for the Next Decade in Oncology

Explore OVN